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Several recent reports, including one in this journal, have reignited the 
debate about whether the calcium-
mobilizing messenger, nicotinic adenine 
nucleotide diphosphate (NAADP) plays 
a central role in the regulation of cal-
cium signaling in pancreatic β-cells.1-5 
These studies have highlighted a role for 
NAADP-induced Ca2+ mobilization not 
only in mediating the effects of the incre-
tin, GLP-1 and the autocrine prolifera-
tive effects of insulin, but also possibly 
a fundamental role in glucose-mediated 
insulin secretion in the pancreatic β-cell.
Introduction
The K
ATP
 channel-dependent hypothesis 
for stimulus-secretion coupling in pan-
creatic β-cells has gained prominence 
in recent years as the major pathway by 
which glucose triggers signaling events to 
bring about membrane depolarization and 
the activation of voltage-dependent cal-
cium channels (VDCCs) and Ca2+ influx, 
the major regulator of insulin granule exo-
cytosis.6 However, several shortcomings 
of this hypothesis have been articulated.7,8 
First, glucose may still evoke Ca2+ signals 
and insulin secretion after knockout of 
K
ATP
 channel components,9-11 and sec-
ondly K
ATP
 channel closure alone is not 
sufficient to depolarize the membrane to 
cause activation of VDCCs. A background 
current, for example, an inward cation cur-
rent is required, together with the closure 
of the K
ATP
 channel which itself increases 
the membrane resistance to cause suffi-
cient depolarization to activate VDCCs. 
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The Ca2+ mobilizing messenger, NAADP 
is gaining prominence as a universal trig-
ger for events at both the ER and at the 
plasma membrane.12-15 It does this by caus-
ing local Ca2+ release from acidic stores, 
which may then be amplified by recruiting 
Ca2+ release channels on the endoplasmic 
reticulum (ER) membrane or activating 
Ca2+-dependent channels at the plasma 
membrane. Recent studies have demon-
strated the presence of NAADP-sensitive 
acidic Ca2+ stores in pancreatic β-cells,1,16-18 
and their role in triggering signaling events 
in β-cells is gathering momentum.
The most recent reports highlight the 
role of NAADP in signal transduction in 
response to activation of autocrine insulin 
receptors.4,5 Another highlights the role of 
NAADP in mediating the effects of the 
incretin, GLP-1.1 Furthermore, a recent 
important development describes a new 
selective membrane-permeant NAADP 
antagonist, Ned-19 which inhibited glu-
cose-evoked calcium spiking in mouse 
pancreatic β-cells in a concentration-
dependent manner.2 Finally, a ground-
breaking discovery has been made recently 
with the identification of the two pore 
channels (TPCs) as NAADP-gated cal-
cium release channels on endo-lysosomal 
membranes and the demonstration that 
NAADP evoked oscillatory non-selec-
tive cation currents in mouse pancreatic 
β-cells, this effect being abolished in cells 
prepared from Tpc2-/- mice.3 These studies 
represent the re-emergence of an interest 
in NAADP signaling in pancreatic β-cells 
that occurred some years ago and cement 
earlier observations on a possible role for 
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been suggested in some cells to be directly 
targeted by NAADP,35,36 although this is 
not universally accepted.37 However, the 
recent identification of two-pore chan-
nels (TPCs) as NAADP receptors,3 this 
finding being subsequently confirmed by 
others,38,39 perhaps provides the most con-
vincing candidates, as they mirror many 
of the properties previously ascribed to 
NAADP-gated Ca2+ release mechanisms 
including endo-lysosomal localization.14,40
TPCs are poorly characterized mem-
bers of the voltage-gated superfamily of 
cation channels. They are an ancient fam-
ily, and a TPC homolog functions as a 
vacuolar channel in plants.41 They consist 
of two-linked 6 transmembrane domain 
units and thus have a total of 12 trans-
membrane alpha helices. It is likely that the 
functional channel is a dimer. There are 
three non-allelic TPC genes in most ani-
mal species, but only TPC1 and TPC2 are 
found in humans and rodents. Expression 
of HsTPCs in HEK293 cells showed them 
to be localized to the endolysosomal sys-
tem, with TPC2 predominantly expressed 
in lysosomes while TPC1 was endosomal. 
In cells overexpressing TPC2, NAADP 
evoked a biphasic Ca2+ release, the first 
phase from acidic stores, whilst the sec-
ond phase was due to amplification by the 
recruitment of ER IP
3
Rs, presumably by 
CICR.3,40 The concentration-dependence 
of NAADP action showed the character-
istic bell-shaped concentration-response 
curve. siRNA TPC2 probes abolished the 
sensitivity to NAADP, and stimulation of 
Ca2+ activated cation currents in mouse 
pancreatic β-cells were absent in cells 
from Tpc2-/- mice. In addition, expression 
of TPC2 in HEK293 cells was associ-
ated with increased [32P]NAADP bind-
ing,3 and immunopurified endogenous sea 
urchin TPC1 and TPC3 complexes bind 
[32P]NAADP with nanomolar affinity.40
Taken together, TPCs represent strong 
candidates as NAADP receptors14,15,42 
and provide for the first time a molecular 
handle with which to investigate NAADP 
signaling.
Calcium Stores  
in Pancreatic β-cells
The traditional model for glucose-evoked 
Ca2+ signaling has emphasized the role of 
increase  cellular NAADP levels, adding to 
growing evidence that it is an intracellular 
messenger.23 The concentration-response 
relationship between NAADP and Ca2+ 
release in β-cells,20,21 in common with 
other mammalian cell types, is described 
as bell-shaped, with maximal Ca2+ release 
evoked by around 100 nM NAADP.28 
Higher concentrations are less effective; 
with micromolar concentrations causing 
apparent desensitization of the NAADP-
sensitive Ca2+ release mechanism in the 
absence of measurable Ca2+ release.1,20,21 
In many cell types, NAADP appears to 
target a separate Ca2+ store, which may be 
acidic in nature such as lysosomes, rather 
than the long-established ER Ca2+ store,29 
although Ca2+ release from acidic stores 
can trigger subsequent Ca2+-induced Ca2+ 
release (CICR) from the ER.14,30,31 Thus 
NAADP has been proposed to serve as a 
key triggering Ca2+ mobilizing messenger, 
not only releasing Ca2+ by directly tar-
geting NAADP-sensitive stores, but also 
acting to coordinate Ca2+ release from 
the ER via IP
3
R and RyR through CICR-
dependent mechanisms.12,14
The Molecular Identity  
of NAADP Receptors
The molecular targets for NAADP have 
been a matter of debate for some time.32 
Pharmacological studies have generally 
supported the idea that NAADP targets 
a mechanism distinct from the two major 
Ca2+ release channels, IP
3
 or RyRs. Of the 
known lysosome resident channels, muco-
lipin 1 was the first to be suggested as the 
target receptor channel for NAADP33 but 
this protein had previously been ruled out 
by others.34 Ryanodine receptors have also 
NAADP in glucose-induced calcium sig-
naling in these cells.19 These earlier studies 
suggested a role for NAADP in mediating 
the autocrine effects of insulin in human 
islets,20 the release of Ca2+ from acidic 
stores in β-cell lines,16 and the role of 
NAADP-evoked calcium release as a criti-
cal mediator of Ca2+ signaling responses to 
glucose in MIN6 cells.17,21 With these new 
studies, NAADP is emerging as an impor-
tant player in the regulation of β-cell Ca2+ 
signaling.
NAADP as a Calcium  
Mobilizing Messenger
NAADP is the most potent of the major 
Ca2+ mobilizing messengers described, 
with activity reported at low nanomolar 
intracellular concentrations.22 It differs 
in structure from the more familiar co-
enzyme NADP by the substitution of the 
nicotinamide moiety by nicotinic acid 
(Fig. 1). Its actions were first reported in 
sea urchin eggs,22 but NAADP is now 
known to have widespread actions in most 
cell types studied.13,23 However, it is fair to 
say that in terms of its synthesis, regula-
tion and mechanism of action, NAADP 
signaling is poorly understood. NAADP 
is thought to be synthesized from NADP 
as a precursor, and the only mammalian 
enzymes that have been demonstrated 
to catalyze this reaction, at least in vitro, 
are ADP-ribosyl cyclases (ARCs) such 
as CD38.24,25 Interestingly, CD38 and 
its alternate Ca2+ mobilizing product, 
cADPR, had previously been linked to 
stimulus-secretion coupling in β-cells26,27 
as discussed below. Various stimuli, includ-
ing agonists acting at a variety of cell sur-
face receptors, have been demonstrated to 
Figure 1. Structure of naaDP. naaDP differs from β-naDP only in that that the base nicotinic 
acid is substituted for nicotinamide.
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cADPR, played a key role in insulin secre-
tion.51 However, given that cADPR targets 
RyRs mainly on the ER, and this organelle 
shapes, rather than has a triggering role in 
evoking Ca2+ signals in β-cells,56 and that 
a role for cADPR in β-cell stimulus-secre-
tion coupling has not been universally 
confirmed,57,58 the role of NAADP was 
investigated since it was shown that CD38 
and ARCs could catalyze NAADP forma-
tion in cell-free systems24 and NAADP 
mobilizes Ca2+ largely from a store sepa-
rate from the ER.
While a number of studies have pro-
vided evidence for the role of ARCs such 
as CD38 in the synthesis of cADPR,59 
evidence for their role in the synthesis of 
endogenous NAADP remains conflict-
ing, with some studies supporting such 
a role,60,61 others arguing against.62 In a 
recent study in β-cells, CD38 was shown 
to contribute to NAADP synthesis stimu-
lated by GLP-1, but this appeared not to 
be the only mechanism for generating 
NAADP.1
CD38 was initially considered an 
ectoenzyme59 but it has now been shown 
that ARCs may also be localized inside 
cells, where they are more appropriately 
sited for production of intracellular mes-
sengers.63 There is growing evidence that 
ARCs, including CD38, may be pres-
ent in endosomes,64 secretory granules63 
and even lysosomes.1 In an interesting 
study, internalization of plasma mem-
brane CD38 was induced by the reduc-
ing agent, L-oxothiazolidine-4-carboxylic 
acid, a pro-drug of cysteine, which like 
glucose enhances dimerization of CD38, 
enhances glucose-mediated Ca2+ signal-
ing and induces antidiabetic effects in 
ameliorating glucose intolerance in db/
db mice.64 The localization of messenger-
synthesising enzymes within organelles 
presents a topological problem in that 
substrates have to be transported in, and 
products out to their targets. However, 
evidence has been presented in the sea 
urchin egg for such processes.63 Moreover, 
the luminal acidic pH may favour enzyme 
activities especially for NAADP genera-
tion and since a base-exchange mechanism 
has been proposed for this messenger,24,25 
nicotinic acid may accumulate there at 
sufficient concentrations for NAADP syn-
thesis by this mechanism.
granules but not the ER, an effect that was 
not blocked by either ryanodine or dan-
trolene, a RyR1 inhibitor.16 It was found 
that photolysis of caged NAADP evoked 
a Ca2+ response that was largely abolished 
by pretreatment with bafilomycin, but 
thapsigargin did not affect the ampli-
tude, although it reduced the duration 
of the response.17 A further study showed 
in mouse primary β-cells that NAADP-
evoked Ca2+ release was blocked by GPN 
and partially inhibited by thapsigargin 
but not by dantrolene.18 Acidic Ca2+ pools 
were shown to be primarily responsible 
for the delayed plateau of Ca2+ release 
after prolonged depolarization of β-cells 
termed the “Ca2+ hump”. The apparent 
large size of this Ca2+ pool may indicate 
that Ca2+ release from the small number of 
lysosomes in β-cells alone cannot account 
for this phenomenon, but might include 
secretory granules or other acidic organ-
elles in addition.18 Additionally, in one 
of the recent studies, NAADP was firmly 
shown to mobilize Ca2+ from acidic stores 
but not the ER in mouse primary β-cells.1 
However, in permeabilized mouse β-cells, 
NAADP was found to be ineffective at 
mobilizing Ca2+.49 There are few reports of 
NAADP efficacy in broken cell systems.28 
One possible explanation is that stores are 
labile, small and coupling to CICR ampli-
fication mechanisms required for detec-
tion are broken.
NAADP Synthesis and  
Regulation
An impetus for studying the role of 
NAADP in β-cells followed on from 
the work of Okamoto and colleagues. In 
1993, they proposed a key role for cADPR 
in stimulus-secretion coupling.26 cADPR 
was proposed to enhance insulin secretion 
in pancreatic β-cells by either mobiliz-
ing Ca2+ from the ER through activat-
ing RyRs26 or at higher concentrations by 
enhancing Ca2+ influx through activating 
plasma membrane TRPM2 channels.50 
Inhibition or genetic ablation of CD38 
function has been correlated with reduced 
Ca2+ responses and insulin secretion in 
response to elevated glucose concentra-
tions,51 and even linked to Type 2 diabe-
tes.27,52-55 Subsequent studies showed that 
CD38, which cyclizes NAD to produce 
Ca2+ influx through L-type  voltage-gated 
Ca2+ channels, with a minor role for 
the ER in shaping the stereotypic Ca2+ 
spikes. Indeed, the earliest Ca2+ response 
observed to be initiated by glucose is a 
decrease ascribed to enhancement of Ca2+ 
uptake by the ER by increase in ATP syn-
thesis43 probably mediated by SERCA2b. 
Pharmacological ablation of SERCA-
mediated pumping of Ca2+ into the ER 
with thapsigargin or genetic ablation 
of SERCA2b and 3 isoforms in mouse 
β-cells generally enhances amplitudes of 
glucose-evoked Ca2+ oscillations.44 Thus 
the ER plays a role in Ca2+ buffering, 
although cycles of uptake and release may 
be important in glucose-mediated fast 
Ca2+ spiking45 and play a prominent role 
in the modulation of Ca2+ spiking by acti-
vation of incretin receptors coupled to IP
3
 
production.46 The finding that NAADP 
targets acidic Ca2+ stores29 has prompted 
the investigation of the role of acidic stores 
in Ca2+ handling in pancreatic β-cells.
In contrast to the ER, little is known 
of the Ca2+ uptake mechanisms in acidic 
stores, nor how Ca2+ is stored in these 
organelles, although polyanions have been 
suggested to play a role.47 However, Ca2+ 
uptake and storage seem to be dependent 
on the maintenance of the pH gradient 
across their membranes. Two classes of 
pharmacological agents have been princi-
pally used to abrogate Ca2+ storage by these 
organelles. The first is bafilomycin and 
related compounds such as concanamycin, 
which inhibit the vacuolar H+-ATPase 
expressed widely in acidic organelles 
including the endolysosomal system and 
secretory granules.48 The ability of these 
compounds to discharge Ca2+ depends on 
the leakiness of stores to both protons and 
Ca2+ and often requires prolonged incuba-
tions. Both nigericin, a protonophore and 
NAADP have been found to accelerate 
Ca2+ leak by these organelles.29 A second 
compound, glycylphenylalanine-2-naph-
thylamide (GPN), causes osmotic lysis 
of acidic stores based on the presence of 
cathepsin C, found principally within 
lysosomes, and is accompanied by bursts 
of Ca2+ release.29 In MIN6 cells in which 
the bioluminescent Ca2+ reporter aequorin 
was targeted to the ER or insulin-contain-
ing secretory granules, it was found that 
NAADP released Ca2+ from secretory 
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glucose-mediated responses has now been 
reported in several studies. The first study 
to suggest this role used the  ability of 
high concentrations of NAADP to desen-
sitize NAADP-evoked Ca2+ release21 in 
MIN6 cells. Using microinjected caged 
NAADP it was found that photolysis of 
low amounts evoked a large Ca2+ release, 
which was largely resistant to inhibition 
by thapsigargin. However, with photoly-
sis of higher amounts of caged NAADP, 
no Ca2+ release was seen. Having estab-
lished conditions for desensitization of 
NAADP-evoked Ca2+ release, cells were 
then challenged with 20 mM glucose. 
Glucose-evoked Ca2+ oscillations were 
greatly suppressed, suggesting a role of 
NAADP in the actual triggering pro-
cesses in β-cell stimulus-secretion cou-
pling. In addition, high affinity binding 
sites for NAADP were found in islets, and 
importantly glucose was able to evoke an 
increase in cellular NAADP levels.21 Since 
NAADP was reported to mobilize Ca2+ 
from acidic stores,29 the effects of disrupt-
ing Ca2+ storage in acidic organelles upon 
glucose-evoked Ca2+ signaling was exam-
ined.17 Bafilomycin (2 µM) abolished 
glucose responses but not those to acetyl-
choline, an incretin acting on β-cell mus-
carinic receptors which are linked to IP
3
 
production and release of Ca2+ from ER 
stores. Conversely, thapsigargin abolished 
acetylcholine but not glucose responses.17 
Taken together, these data are suggestive 
of a role for NAADP-mobilization from 
acidic stores in the glucose-mediated trig-
gering response. The employment of a 
newly developed membrane-permeant 
selective NAADP antagonist, Ned-19 
has confirmed these findings. Ned-19 
is weakly fluorescent and labels acidic 
stores in pancreatic β cells, an effect that 
is reduced by prior treatment with the 
membrane-permeant NAADP analogue, 
NAADP-AM.2 Ned-19 abolished glucose-
evoked Ca2+ responses in a concentration-
dependent manner (Fig. 3),2 although it 
did not affect activation of voltage-gated 
Ca2+ channels by potassium depolariza-
tion or mitochondrial metabolism. Since 
the large glucose-evoked Ca2+ signals are 
dependent on extracellular Ca2+ as they 
rely on depolarization-evoked openings of 
VDCCs, what then is the role of NAADP-
mediated Ca2+ release from acidic stores? 
suggesting other enzymes may also be 
involved in their production.1
Another receptor on β-cells linked 
to Ca2+ signals dependent on NAADP-
sensitive Ca2+ release is the insulin recep-
tor. Paracrine or autocrine effects of 
insulin receptors have been shown to 
evoke Ca2+ signals in β-cells.70,71 In the 
first report of NAADP effects in human 
β-cells, microinjection of NAADP at 
different concentrations displayed the 
hallmark bell-shaped curve for Ca2+ 
release with maximum effects at 100 
nM. Injecting a desensitizing concentra-
tion of 10 mM, insulin-evoked Ca2+ sig-
nals were abolished. Furthermore, the 
insulin concentration-response curve 
was bell-shaped for Ca2+ release, mirror-
ing that for NAADP. As for GLP-1, the 
initial phase of Ca2+ release evoked by 
insulin was insensitive to SERCA pump 
inhibitors suggesting release from a non-
ER store. The second phase of insulin-
evoked Ca2+ release was partially blocked 
by the IP
3
R antagonist, xestospongin but 
not by ryanodine. Insulin stimulation of 
islets lead to increased insulin content but 
not secretion, thus implicating a role for 
NAADP-mediated Ca2+ signaling in insu-
lin regulation of insulin gene expression. 
Interestingly, as we describe below, while 
NAADP may depolarize β-cell mem-
branes (Fig. 2), insulin apparently does 
not.70
As recently reported in this journal, 
the role of NAADP in the mediation of 
insulin responses has been reinvestigated. 
In this study, NAADP was again impli-
cated in initiating the Ca2+ mobilizing 
effects of insulin, with a sequential role 
for IP
3
 and cADPR consistent with the 
triggering role for NAADP. Here a role 
for insulin-mediated NAADP-dependent 
signaling was implicated in the control of 
β-cell proliferation.4 Additionally, insulin 
was shown to increase islet NAADP levels, 
in contrast to the previous report from the 
same group.1
A Triggering Role for NAADP  
in Nutrient-Mediated  
Calcium Signaling
Perhaps one of the most interesting new 
aspects in this area is that a key role for 
NAADP for the actual triggering of 
Although NAADP has been found to 
increase in islets and β-cells in response 
to glucose, GLP-1 and insulin, stimulus-
coupling to intra-organellar enzymes 
again presents a topological problem. At 
present these mechanisms are unclear. 
However, in β-cells, ATP,65 cGMP-depen-
dent kinases, PKC4 and cAMP (perhaps 
via EPAC)1 have all been proposed. Our 
understanding of the way in which β-cell 
agonists couple to the enzymatic synthesis 
of NAADP and cADPR is in urgent need 
of further study in common with the situ-
ation in other systems, as is the identifica-
tion of other possible NAADP synthases.
NAADP and Receptor-mediated 
Ca2+ Signaling
Incretins such as GLP-1 do not trig-
ger insulin secretion per se but potenti-
ate the actions of glucose.66 They act at 
cell surface receptors and activate signal 
transduction processes. A recent report 
has demonstrated that GLP-1 is coupled 
to both NAADP and cADPR synthe-
sis and Ca2+ release from acidic and ER 
stores.1 Unusually in this study, NAADP 
was shown to increase Ca2+ in β-cells in 
response to extracellular application of 
NAADP at concentrations similar to those 
required for responses in studies employ-
ing whole cell patch clamp application.2
GLP1 (10 nM) was found to evoke 
Ca2+ signals only in the presence of ele-
vated glucose.1,67 Ca2+ signals were main-
tained with the initial phase ascribed to 
NAADP whilst thapsigargin and cADPR 
antagonists (but not IP
3
R blockers) caused 
the abolition or abbreviation of the second 
maintained phase. Both desensitizing con-
centrations of NAADP or pretreatment 
with bafilomycin abolished both phases 
of the GLP-1 response. Thus the initial 
transient evoked by NAADP is required 
for the second phase of Ca2+ release evoked 
by cADPR. This is similar to models of 
NAADP trigger action in other systems12 
such as the fertilization of the sea urchin 
egg, where NAADP can fire a Ca2+ wave 
first by evoking Ca2+ release from acidic 
stores and then by recruiting ER CICR 
mechanisms.68,69
Experiments with Cd38-/- islets 
showed a partial dependence on CD38 
for both NAADP and cADPR synthesis, 
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glucose-mediated Ca2+ signaling in TPC 
knockout mice will be important in our 
understanding of the role of NAADP in 
β-cell Ca2+  signaling. Preliminary results 
already reported  suggest that glucose-
evoked Ca2+ spiking and membrane depo-
larization is abolished or greatly attenuated 
in Tpc2-/- β-cells.78 Further studies of 
Tpc2-/-, Tpc1-/- and possibly Tpc1/Tpc2 
double knockout β-cells that are ongo-
ing may provide exciting new information 
about a possible new triggering pathway of 
K
ATP
-independent, it may synergize with 
K
ATP
-dependent mechanisms in the trig-
gering phase for glucose action. A major 
breakthrough in our understanding of 
NAADP-mediated Ca2+ release has come 
from the recent discovery of two pore 
channels (TPCs) as NAADP-gated Ca2+ 
release channels of endolysosomal com-
partments.3,14 Importantly, as described 
above, in β-cells from Tpc2-/- mice, 
NAADP no longer evokes the oscilla-
tory depolarizing currents. The study of 
One clue has come from intracellular per-
fusion of β-cells with NAADP. NAADP 
evokes a series of oscillatory depolarizing 
cation currents, which are abolished by 
Ned-19.2 The channels carrying these 
currents are unknown but intriguingly 
they are blocked by TRPM4/5 blockers 
(unpublished observations), and Ca2+-
activated TRPM4 and TRPM5 channels 
in the plasma membrane have been sug-
gested to play an important role in shap-
ing Ca2+ signals72 and controlling insulin 
secretion in β-cells.73-75 Thus NAADP-
evoked Ca2+ release via TPCs from acidic 
stores just under the plasma membrane 
could comprise a signaling module with 
Ca2+-activated TRPM4/5 channels medi-
ating plasma membrane depolarization by 
NAADP (Fig. 4). Interestingly, this depo-
larizing effect seems unique to NAADP 
as a Ca2+ mobilizing messenger, since 
IP
3
 has been shown to hyperpolarize the 
β-cell membrane.76 One possibility then 
is that NAADP signaling mechanisms 
contribute together with the closure of 
K
ATP
 channels to the depolarization of the 
β-cell membrane to a threshold for acti-
vation of VDCCs (Fig. 2). The operation 
of this triggering mechanism may explain 
how glucose still evokes Ca2+ transients in 
β-cells from knockout mice with defects 
in Kir6.2 or SUR1, the components of 
the K
ATP
 channel. Since NAADP produc-
tion and Ca2+ release may be localized to 
regions just under the plasma membrane 
such Ca2+ microdomains, as previously 
hypothesized,77 may play a key role in 
β-cell excitability. The currents gener-
ated by this mechanism in response to 
glucose may be small and transient, but 
sufficient to depolarize the membrane 
especially when the membrane resistance 
is increased by closure of K
ATP
 channels. 
Thus, although this mechanism is strictly 
Figure 2. naaDP-evoked Ca2+-activated cation currents in mouse pancreatic β-cells. (a) Ca2+-
dependent current traces are from mouse β cells that were voltage-clamped with a patch pipette 
containing 100 nm naaDP in the presence or absence of the membrane permeant naaDP antag-
onist ned-19 (100 µm) in the bathing solution. (B) Cation currents at -70 mV evoked by intracellular 
dialysis of 100 nm naaDP via patch pipette in whole cell mode in pancreatic β-cells isolated from 
wild-type (top) and Tpc2 knockout (bottom) mice. the left hand parts show a single representa-
tive trace, whilst the right hand part shows records from several cells [taken from ref. 2 and 3].
Figure 3. the naaDP antagonist blocks glucose-evoked Ca2+ signaling in mouse primary pancreatic beta cells. ned-19 reduces glucose-induced Ca2+ 
increases in a concentration-dependent manner. Islets were pre-incubated with the indicated concentration of ned-19 for 30 min before the addition 
of 15 mm glucose [taken from ref. 2].
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